Screening for coronary heart disease: Has the time for universal imaging arrived?
Michael S. Lauer, MD
Director, Division of Prevention and Population Science, National Heart, Lung, and Blood Institute, National Institutes of Health; Contributing Editor, JAMA
Address: Michael S. Lauer, MD, Division of Prevention and Population Science, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 10122, Bethesda, MD 20892; e-mail: email@example.com
Dr. Lauer receives support from the National Heart, Lung, and Blood Association (R01 HL-66004, R01 HL-072771, and P50 HL-77107, and K12 HD049091). He reports no personal financial relationships with any private commercial pharmaceutical, device, or imaging companies.
ABSTRACTThe Screening for Heart Attack Prevention and Education (SHAPE) Task Force has recommended a strategy of screeninig for coronary heart disease in which nearly all middle-aged and older adults would undergo an imaging test. However, this approach is not supported by evidence and is not endorsed by professional societies or the US Preventive Services Task Force. Physicians should follow established guidelines such as those of the third AdultTreatment Panel of the National Cholesterol Education Program.